alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Nicholas Ryan HOLLOWAY, petitioner, v. Wendy KELLEY, Director, Arkansas Department of Correction.

No. 18-8655.

Supreme Court of the United States

May 20, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEET OF AVIVA PETROLEUM INC. AND SUBSIDIARIES AS
OF SEPTEMBER 30, 1996 AND THE RELATED CONDENSED CONSOLIDATED STATEMENT OF
OPERATIONS FOR THE NINE MONTH PERIOD ENDED SEPTEMBER 30, 1996 AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                           4,127
<SECURITIES>                                         0
<RECEIVABLES>                                    3,290
<ALLOWANCES>                                         0
<INVENTORY>                                        839
<CURRENT-ASSETS>                                 8,518
<PP&E>                                          87,221
<DEPRECIATION>                                  50,660
<TOTAL-ASSETS>                                  46,862
<CURRENT-LIABILITIES>                           10,134
<BONDS>                                          7,892
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,574
<OTHER-SE>                                      25,057
<TOTAL-LIABILITY-AND-EQUITY>                    46,862
<SALES>                                         10,512
<TOTAL-REVENUES>                                10,512
<CGS>                                            8,780
<TOTAL-COSTS>                                    8,780
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 602
<INCOME-PRETAX>                                   (197)
<INCOME-TAX>                                       339
<INCOME-CONTINUING>                               (536)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (536)
<EPS-PRIMARY>                                    (0.02)
<EPS-DILUTED>                                        0
        

</TABLE>
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2296 Referred in Senate (RFS)]

  2d Session
                                H. R. 2296

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           September 13, 2000

   Received; read twice and referred to the Committee on Energy and 
                           Natural Resources

_______________________________________________________________________

                                 AN ACT

 
To amend the Revised Organic Act of the Virgin Islands to provide that 
the number of members on the legislature of the Virgin Islands and the 
number of such members constituting a quorum shall be determined by the 
          laws of the Virgin Islands, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SIZE OF LEGISLATURE.

    Section 5(b) of the Revised Organic Act of the Virgin Islands (48 
U.S.C. 1571(b)) is amended--
            (1) by striking ``fifteen''; and
            (2) by inserting after the first sentence the following: 
        ``The number of such senators shall be determined by the laws 
        of the Virgin Islands.''.

SEC. 2. NUMBER CONSTITUTING QUORUM.

    The first sentence of section 9(a) of the Revised Organic Act of 
the Virgin Islands (48 U.S.C. 1575(a)) is amended to read as follows: 
``The number of members of the legislature needed to constitute a 
quorum shall be determined by the laws of the Virgin Islands.''.

            Passed the House of Representatives September 12, 2000.

            Attest:

                                                 JEFF TRANDAHL,

                                                                 Clerk.
```
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Microbiology, Infectious Diseases and AIDS Initial Review Group; Microbiology and Infectious Diseases Research Study Section Microbiology and Infectious Diseases Research Study Section.                    

*Date:*                         June 16-17, 2022.                    

*Time:*                         10:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F40A, Rockville, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Robert C. Unfer, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F40A, Rockville, MD 20852, (240) 669-5035,                         *robert.unfer@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: May 19, 2022.

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-11220 Filed 5-24-22; 8:45 am]

BILLING CODE 4140-01-P
ZIMING SHEN, petitioner, v. CITY OF NEW YORK, NEW YORK, et al.

No. 17-1512.

Supreme Court of the United States

Oct. 1, 2018.

*79Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.
MICRO COMPONENT TECHNOLOGY, INC.

                                    FORM 10-Q

                  COMPUTATION OF EARNINGS PER COMMON SHARE AND
                             COMMON EQUIVALENT SHARE
                      (In thousands, except per share data)


                                                           THREE MONTHS ENDED
                                                           -------------------
                                                           SEPT. 27, SEPT. 28,
PRIMARY                                                      1997      1996
-------                                                     -------   -------

Net income (loss)                                           $    16   $(1,128)
                                                            =======   =======

Weighted average number of common shares outstanding
        during the period                                     7,054     7,020
Shares issuable on exercise of stock options and warrants
        less shares repurchaseable from the proceeds            351      --
Shares issuable on conversion of redeemable preferred
        stock                                                   316       316
                                                            -------   -------

Common and common equivalent shares - primary                 7,721     7,336
                                                            =======   =======

Net income (loss) per share - primary                       $   .00   $  (.15)
                                                            =======   =======



FULLY DILUTED

Net income (loss)                                           $    16   $(1,128)
                                                            =======   =======

Common and common equivalent shares - primary                 7,721     7,336
Shares issuable on exercise of stock options and
        warrants less shares repurchaseable from
        the proceeds                                           --        --
                                                            -------   -------

Common and common equivalent shares - fully diluted           7.721     7,336
                                                            =======   =======


Net income (loss) per share - fully diluted                 $   .00   $  (.15)
                                                            =======   =======
<PAGE>
 
                                                                    Exhibit 10.1
 
                       FIRST AMENDMENT TO SECOND AMENDED
                       ---------------------------------
                          AND RESTATED LOAN AGREEMENT
                          ---------------------------



     This First Amendment to Second Amended and Restated Loan Agreement as of
June 30, 1998, by and between Citizens Bank of Massachusetts (herein "BANK"),
and DM Management Company, a Delaware corporation (herein "BORROWER:).

     Reference is made to a certain Loan Agreement made as of June 5, 1997 by
and between BANK and BORROWER, as the same has been amended and restated in a
certain Amended and Restated Loan Agreement dated October 31, 1997, and in a
certain Second Amended and Restated Loan Agreement dated March 5, 1998 (as so
restated, the "Loan Agreement").

                                  WITNESSETH:
                                  -----------


     WHEREAS, the BORROWER wishes to amend certain of the provisions of the Loan
Agreement; and

     WHEREAS, THE BANK is willing to do so on the terms, provisions and
conditions contained herein;

     NOW, THEREFORE, in consideration of the covenants and agreements herein
contained, the parties hereby agree that the Loan Agreement is hereby amended as
follows:

     Paragraph 11.11 of the Loan Agreement is hereby deleted and the following
inserted in lieu thereof:

         11.11 The BORROWER will not, for any four (4) consecutive fiscal
     quarters, permit DEBT SERVICE COVERAGE to be less than 1.25 to 1. Such
     covenant shall be calculated quarterly based upon the preceding 12 months
     of operations commencing with the twelve month period year ending June 30,
     1997. Notwithstanding the foregoing, the calculation for the quarters
     ending June 30, 1998 and September 30, 1998 shall be made without any
     reference to UNFINANCED CAPITAL EXPENDITURES.

     This Amendment shall take effect as of the date first above written.
<PAGE>
 
     Except as hereby amended, the Loan Agreement is hereby ratified, confirmed
and republished.

     IN WITNESS WHEREOF, the parties hereto have set their hands and seals as of
the date first above written.

Witness:                  DM MANAGEMENT COMPANY


                            By: /s/ Peter J. Tulp
                               ___________________________________
                               Peter J. Tulp, Corporate Controller


                          CITIZENS BANK OF MASSACHUSETTS

                            By: /s/ Lori B. Leeth
                               ____________________________________
                               Lori B. Leeth, Senior Vice President
IN THE SUPREME COURT OF PENNSYLVANIA

In the Matter of

SUSAN ANN LOWDEN :

:

:

:

:

:

:

:

:

: No. 2747 Disciplinary Docket No. 3

Board File No. C1

- 20

- 316

(Supreme Court of N ew Jersey

, D

- 5 5 September Term 2019)

Attorney Registration No. 60228

(Out of State)

ORDER

PER CURIAM

AND NOW , this 17 th day of Nov ember, 2020, having failed to respond to a Notice

and Order directing her to provide reasons against the imposition of reciprocal discipline,

Susan Ann Lowden is suspended from the practice of law for a period of six months in

the Commonwealth of Pennsylva nia. She shall comply with all the provisions of

Pa.R.D.E. 217.
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     THIS SCHEDULE  CONTAINS SUMMARY  FINANCIAL  INFORMATION  EXTRACTED FROM THE
REGISTRANT'S AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED
DECEMBER  31,  1996  AND IS  QUALIFIED  IN ITS  ENTIRETY  BY  REFERENCE  TO SUCH
FINANCIAL STATEMENTS
</LEGEND>
<CIK>                         0000917321

<NAME>                        FinishMaster Inc.
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. Dollars

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-START>                                 APR-1-1996
<PERIOD-END>                                   DEC-31-1996
<EXCHANGE-RATE>                                1.000
<CASH>                                         300
<SECURITIES>                                   0
<RECEIVABLES>                                  13,452
<ALLOWANCES>                                   700
<INVENTORY>                                    24,828
<CURRENT-ASSETS>                               39,139
<PP&E>                                         9,437
<DEPRECIATION>                                 2,866
<TOTAL-ASSETS>                                 66,477
<CURRENT-LIABILITIES>                          16,320
<BONDS>                                        0
<COMMON>                                       6,000
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<OTHER-SE>                                     26,326
<TOTAL-LIABILITY-AND-EQUITY>                   66,477
<SALES>                                        95,822
<TOTAL-REVENUES>                               95,822
<CGS>                                          61,931
<TOTAL-COSTS>                                  31,325
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             1,296
<INCOME-PRETAX>                                1,270
<INCOME-TAX>                                   610
<INCOME-CONTINUING>                            660
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   660
<EPS-PRIMARY>                                  0.11
<EPS-DILUTED>                                  0.11



</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-1-2000
<PERIOD-END>                                   MAR-31-2000
<CASH>                                         288,845
<SECURITIES>                                   0
<RECEIVABLES>                                  2,428,301
<ALLOWANCES>                                   (110,000)
<INVENTORY>                                    1,437,955
<CURRENT-ASSETS>                               5,835,811
<PP&E>                                         6,184,153
<DEPRECIATION>                                 (1,213,461)
<TOTAL-ASSETS>                                 12,964,525
<CURRENT-LIABILITIES>                          4,057,031
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       2,912
<OTHER-SE>                                     5,690,824
<TOTAL-LIABILITY-AND-EQUITY>                   12,964,525
<SALES>                                        4,343,381
<TOTAL-REVENUES>                               4,343,381
<CGS>                                          2,403,975
<TOTAL-COSTS>                                  2,403,975
<OTHER-EXPENSES>                               2,138,169
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             185,808
<INCOME-PRETAX>                                (384,571)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (384,571)
<DISCONTINUED>                                 62,178
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (322,393)
<EPS-BASIC>                                    (0.11)
<EPS-DILUTED>                                  (0.11)



</TABLE>
UNITED STATES DISTRICT COURT

EASTERN DISTRICT OF TEXAS

Beaumont Division

THE HONORABLE JUDGE MARCIA A. CRONE

DATE: November 21, 2024

CASE 

NUMBER: 1:23CV281

LOCATION: Beaumont – Courtroom 3

CASE 

STYLE: GOODYEAR TIRE & RUBBER

COURTROOM DEPUTY: Julia Colyer CO,

COURT REPORTER: Ruth Weese ATTY FOR PLAINTIFF: Brandon Monk

INTERPRETER: None

CALLED: 4:06 PM

ATTYS FOR 

DEFENDANT: Urvashi Morolia

ADJOURNED: 4:34 PM

DURATION: 28 Minutes

SHOW CAUSE HEARING

This day comes the parties by their attorneys and the following proceedings are held before the Honorable 

Judge Marcia A. Crone in Beaumont, Texas: 

4:06 PM The Court calls the case. Plaintiff’s counsel Brandon Monk announces his appearance on behalf of James Gauthier. 

Defendant’s counsel Urvashi Morolia is present on behalf of Goodyear Tire & Rubber Co. 

4:08 PM Court addresses Monk regarding CMECF document 41. Monk was unable to provide the documents listed in the 

order to show cause. Court addresses Morolia. 

4:27 PM Court recesses to allow Morolia to gather information requested by the Court.

4:28 PM Court resumes. Morolia reports that their firm spent more than 10 hours examining document 41, at a cost of more 

than $7,000.00.

4:30 PM Court orders Monk be sanctioned to pay a $2,000 fine and attend training regarding ethics and Artificial Intelligence.

Court also orders Monk to apprise his client of the situation.

4:34 PM Court adjourns.

Case 1:23-cv-00281-MAC Document 47 Filed 11/21/24 Page 1 of 1 PageID #: 537
<PAGE>

EXHIBIT 31.2

CERTIFICATION

I, Michael A. Doyle, certify that:

1. I have reviewed this annual report on Form 10-K of EasyLink Services
Corporation;

2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4. The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

     (a)  Designed such disclosure controls and procedures, or caused such
          disclosure controls and procedures to be designed under our
          supervision, to ensure that material information relating to the
          registrant, including its consolidated subsidiaries, is made known to
          us by others within those entities, particularly during the period in
          which this annual report is being prepared;

     (b)  Evaluated the effectiveness of the registrant's disclosure controls
          and procedures and presented in this report our conclusions about the
          effectiveness of the disclosure controls and procedures, as of the end
          of the period covered by this report based on such evaluation; and

     (c)  Disclosed in this report any change in the registrant's internal
          control over financial reporting that occurred during the registrant's
          most recent fiscal quarter (the registrant's fourth fiscal quarter in
          the case of an annual report) that has materially affected, or is
          reasonably likely to materially affect, the registrant's internal
          control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent function):

     (a)  All significant deficiencies and material weaknesses in the design or
          operation of internal controls over financial reporting which are
          reasonably likely to adversely affect the registrant's ability to
          record, process, summarize and report financial information; and

     (b)  Any fraud, whether or not material, that involves management or other
          employees who have a significant role in the registrant's internal
          controls over financial reporting.

Dated: March 27, 2007


/s/ Michael A. Doyle
-------------------------------------
Michael A. Doyle
Vice President and Chief Financial
Officer


                                       73